1192PEvaluation of OX40 receptor density, influence of IgG Isotype and dosing paradigm in anti-OX40-mediated efficacy and biomarker responses with PD-1 blockade. (23rd October 2018) - Jackson, H; Bhattacharya, S; Bojczuk, P; Kilian, D; Seestaller Wehr, L; Hahn, A; Shi, H; Bi, M; Adam, M; Jing, J; Morley, P; Hopson, C; et al.